Michael E. Castagna, PharmD
2017
In 2017, Michael E. Castagna, PharmD earned a total compensation of $1.3M as Chief Executive Officer at MannKind.
Compensation breakdown
| Non-Equity Incentive Plan | $247,708 |
|---|---|
| Option Awards | $606,160 |
| Salary | $458,718 |
| Other | $20,648 |
| Total | $1,333,234 |
PharmD received $606.2K in option awards, accounting for 45% of the total pay in 2017.
PharmD also received $247.7K in non-equity incentive plan, $458.7K in salary and $20.6K in other compensation.
Rankings
In 2017, Michael E. Castagna, PharmD's compensation ranked 7,590th out of 14,666 executives tracked by ExecPay. In other words, PharmD earned more than 48.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 7,590 out of 14,666 | 48th |
Division Manufacturing | 2,841 out of 5,768 | 51st |
Major group Chemicals And Allied Products | 923 out of 2,074 | 56th |
Industry group Drugs | 716 out of 1,730 | 59th |
Industry Pharmaceutical Preparations | 558 out of 1,329 | 58th |
Source: SEC filing on April 10, 2020.
PharmD's colleagues
We found seven more compensation records of executives who worked with Michael E. Castagna, PharmD at MannKind in 2017.
2017
Michael Castagna
MannKind
Chief Executive Officer
2017
Stuart Tross
MannKind
Chief People and Workplace Officer
2017
David Thomson
MannKind
General Counsel
2017
Matthew Pfeffer
MannKind
Chief Executive Officer
2017
Joseph Kocinsky
MannKind
Chief Technology Officer
2017
Rosabel Alinaya
MannKind
Chief Financial Officer
2017
Steven Binder
MannKind